Astrazeneca Pharma India Ltd
₹5957
+6.50 (0.11%)
Thu, 22 Oct 2026, 07:45 pm
Astrazeneca Pharma India News
AstraZeneca Pharma India opens new Mumbai office
AstraZeneca Pharma India Limited inaugurated a 25,600 sq ft corporate office in Mumbai to support its growing clinical trial and commercial operations.
16 Oct 2026
companies
AstraZeneca Pharma India gets ESG rating of 73
AstraZeneca Pharma India Limited received an ESG rating of 73 from NSE Sustainability Ratings for FY26. The rating was independently assigned based on public disclosures.
16 Oct 2026
companies
AstraZeneca Pharma fined ₹2.38 lakh for ROC filing delay
AstraZeneca Pharma India Ltd received a penalty order from the Registrar of Companies for delayed filing of Form MR-2 regarding the appointment of Dr. Sanjeev Kumar Panchal as Managing Director in 2023.
18 Sept 2026
companies
AstraZeneca Pharma India accepts resignation of Dr. Sandeep Arora
AstraZeneca Pharma India Limited announced the resignation of Dr. Sandeep Arora, Director – Medical Affairs, effective September 15, 2026. The company is seeking a replacement.
15 Sept 2026
companies
AstraZeneca Pharma India gets ESG rating of 64
Crisil ESG Ratings assigned AstraZeneca Pharma India Ltd an ESG score of 64 for FY26 based on public data. The firm was not engaged by the company.
02 Sept 2026
companies
Market Current News
Khazanchi Jewellers Limited
Khazanchi Jewellers gets in-principle approval for main board migration
Khazanchi Jewellers Limited received in-principle approval from BSE and NSE to migrate from the SME platform to the Main Board. The approvals are valid for 45 days.
21 Oct 2026
ipo
Core4 Engineers SME IPO: ₹285 Cr Order Book
Core4 Engineers Limited files DRHP for SME IPO. The Mysore-based EPCC firm reports ₹91.34 Cr FY26 revenue and a ₹285.83 Cr order book, seeking funds for working capital.
21 Oct 2026
ipo
SFC Env Tech IPO: ₹150 Cr Fresh Issue
SFC Environmental Technologies files DRHP for a ₹150 crore fresh issue. The Navi Mumbai-based firm holds 80% market share in SBR technology with FY26 revenue at ₹803.63 crore.
21 Oct 2026
ipo
EAAA India Alternatives IPO: ₹1,200 Cr OFS
EAAA India Alternatives files DRHP for a ₹1,200 crore Offer for Sale. No fresh issue; proceeds go to promoters. AUM stands at ₹953,448.78 million.
21 Oct 2026
ipo
Paras Healthcare IPO Day 1: Demand Sluggish at 0.08x
Paras Healthcare IPO saw weak response on Day 1 with overall subscription at 0.08x. Retail led demand at 0.41x, while QIB interest remained nil.
21 Oct 2026
ipo